CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Arbutus Biopharma Corp Company Snapshot
Arbutus Biopharma Corp operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arbutus Biopharma Corp with three other pharmaceutical manufacturers in North America: Lineage Cell Therapeutics Inc of the United States (2018 sales of $4.99 million of which 100% was Synthetic Solutions), Fate Therapeutics Inc of the United States ($4.74 million of which 100% was Biopharmaceuticals), and Titan Pharmaceuticals Inc which is also based in the United States ($6.62 million of which 100% was Development of Pharmaceutical Products).

Sales Analysis. During the year ended December of 2018, sales at Arbutus Biopharma Corp were C$7.73 million (US$5.80 million). This is a sharp decrease of 44.2% versus 2017, when the company's sales were C$13.86 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Arbutus Biopharma Corp
  Stock Performance Chart for Arbutus Biopharma Corp
 
  Stock Data: Recent Stock Performance:
  Current Price (8/16/2019): 2.00
(Figures in Canadian Dollars)
1 Week -8.6%   13 Weeks -11.7%  
4 Weeks -38.2%   52 Weeks -83.2%  
 
Arbutus Biopharma Corp Key Data:
  Ticker: ABUS Country: Canada
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 7,725,409
(Year Ending Jan 2019).
Employees: 80
  Currency: Canadian Dollars Market Cap: 113,416,093
  Fiscal Yr Ends: December Shares Outstanding: 56,850,172
  Share Type: Common Closely Held Shares: 23,740,805
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.